There needs to be some new bulk orders from partners outside of...

There needs to be some new bulk orders from partners outside of iTEST in China to back up the story that we are going to reach US$44m in smart packaged solutions sales this year... FLC was set up for a really nice run at the start of this quarter, but no announcements on smart pacakged solutions (Aspiral/Nirobox/SUBRE) for over a quarter and the market is no more clearer as to whether this strategy is actually working.

Once FLC are able to give the market some tangible evidence that we are indeed going to be profitable in Q4 this year and there is an accelerated uptake of MABR in China/globally ... then the re-rating will take shape very swiftly.

Thus far, the sales to date (or lack of) hasn't quite convinced the market that this will actually eventuate.

Personally I believe this provides a great opportunity to top-up ... however it hasn't quite fallen enough to trigger my orders ... I continue to wait patiently.